Stanozolol Injectable 50mg Ergo



Product Description: Stanozolol Injectable 50mg Ergo

Stanozolol Injectable 50mg Ergo is a highly effective anabolic steroid that is widely used by both amateur bodybuilders and experienced athletes. This injectable form of Stanozolol offers numerous benefits for those looking to enhance their performance and achieve their fitness goals.

Product Details

  • Product: Stanozolol Injectable 50mg Ergo
  • Dosage: Each vial contains 50mg of Stanozolol
  • Form: Injectable solution
  • Manufacturer: Ergo Pharmaceuticals

Dosage and Course of Use

For amateur bodybuilders, a recommended dosage of Stanozolol Injectable 50mg Ergo is 50mg every other day. This dosage allows for steady gains in muscle mass, strength, and endurance without overwhelming the body. The course of use typically lasts for 6-8 weeks.

Experienced athletes can opt for a higher dosage of 100mg every other day, depending on their tolerance and goals. However, it is crucial to consult with a healthcare professional or experienced coach before increasing the dosage.

Benefits of Use

  • Promotes lean muscle growth: Stanozolol Injectable 50mg Ergo helps in the development of lean muscle mass, resulting in a more defined and sculpted physique.
  • Enhances strength and endurance: This steroid improves overall strength and endurance, allowing athletes to push their limits during intense workouts and competitions.
  • Reduces water retention: Unlike some other steroids, Stanozolol Injectable 50mg Ergo does not cause water retention, ensuring a more dry and vascular appearance.
  • Improves athletic performance: By increasing red blood cell production, this steroid enhances oxygen-carrying capacity, leading to improved stamina and performance.

Peculiarities of Use and Dosage

It is important to note that Stanozolol Injectable 50mg Ergo should not be used for extended periods or in excessive dosages, as it may lead to adverse effects on liver function. Regular liver function tests are recommended during the course of use to monitor any potential issues.

Additionally, it is crucial to follow a proper post-cycle therapy (PCT) after completing a Stanozolol cycle to restore natural hormone production and minimize any potential side effects.

Possible Adverse Reactions

  • Liver toxicity: Stanozolol Injectable 50mg Ergo can strain the liver, especially with prolonged or high-dosage use. Regular liver function tests are essential.
  • Androgenic effects: Some users may experience androgenic side effects such as acne, oily skin, and hair loss, especially if predisposed to these conditions.
  • Cardiovascular issues: Stanozolol can negatively impact cholesterol levels, leading to an increased risk of cardiovascular problems. Regular monitoring is advised.

Why Choose OrderSteroidsUK

When it comes to purchasing Stanozolol Injectable 50mg Ergo or any other performance-enhancing products, OrderSteroidsUK is your trusted online sports pharmacy in England. Here’s why you should choose us:

  • Authentic products: We only offer genuine and high-quality products from reputable manufacturers, ensuring your safety and satisfaction.
  • Discreet packaging: Your privacy is our priority. We provide discreet packaging and secure delivery to protect your personal information.
  • Competitive prices: We offer competitive prices without compromising on product quality, making us a cost-effective choice for your fitness needs.
  • Knowledgeable customer support: Our dedicated customer support team is available to assist you with any queries or concerns you may have, providing reliable guidance throughout your purchasing journey.

Experience the benefits of Stanozolol Injectable 50mg Ergo and achieve your fitness goals with confidence by choosing OrderSteroidsUK as your trusted supplier.

Additional information

Active ingredient

Stanozolol injection

Active ingredient, mg


form of production


1 bottle, ml


Bottles per pack, pcs.





There are no reviews yet.

Be the first to review “Stanozolol Injectable 50mg Ergo”

Your email address will not be published. Required fields are marked *